Form EFFECT Bluejay Diagnostics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 26, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bluejay Diagnostics completes enrollment in sepsis IL-6 study
- Antares Labs Launches to Build AI That Thinks, Decides, And Acts Alongside Real Estate's Largest Institutions
- S&P Global to Acquire Majority Stake in Agusto & Company Limited, Expanding Ratings' Presence in Africa's Debt Markets
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
